Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

CDC Director Susan Monarez Defies Ouster, Vows To Protect Science Amid Robert Kennedy Jr. Vaccine Policy Clash

Susan Monarez, confirmed as Centers for Disease Control and Prevention director in July 2025, refused to resign on Wednesday after reports of her removal sparked a major public health controversy.

Benzinga

FDA approves updated COVID-19 vaccines with new restrictions, potentially limiting access for healthy children

Guidance around COVID-19 vaccines has once again shifted after the Food and Drug Administration on Aug. 27, 2025, approved updated shots for the fall season, but for a more limited group than in prior seasons.

The Conversation

RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines

Health and Human Services Secretary Robert F. Kennedy Jr. announced on social media that the emergency use authorizations for COVID-19 vaccines have now been rescinded.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Getting a COVID-19 vaccine is getting more and more difficult. Here’s why

It depends on your age, insurance coverage, health and finding a health care professional who will give you the shot

The Independent UK

FDA approves new Covid-19 vaccines in US but limits who can get them

Agency authorizes shots for those 65 and older, with young people eligible if they have underlying medical conditions

The Guardian - US

FDA approves updated COVID-19 shots but limits access for some kids and adults

The Food and Drug Administration has approved updated COVID-19 vaccines for the upcoming fall and winter season

The Independent UK

FDA sets more limited framework for COVID-19 vaccines - Roll Call

The FDA approved COVID-19 vaccines under a more limited framework after rescinding the emergency use authorizations previously in place.

Roll Call

Read news from The Economist, FT, and more,
with one subscription

Salmonella and listeria concerns spark pet food recall

IN FULL

The Independent UK

BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment

BioXcel Therapeutics Inc. (NASDAQ:BTAI) announced that its SERENITY At-Home Phase 3 trial of BXCL501—its sublingual dexmedetomidine film for acute agitation in bipolar disorder or schizophrenia—met its primary endpoint.

Benzinga

Dog and cat food recalled over salmonella and listeria concerns as warning issued to owners

The recalled pet food was sold in seven states

The Independent UK

Texas Legislature approves bill making ivermectin an over-the-counter drug

Some people use the drug to treat COVID, even though it’s not approved by the FDA for such use. The bill now awaits the governor’s signature.

The Texas Tribune

BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know

BioXcel Therapeutics Inc. (NASDAQ:BTAI) experienced significant after-hours momentum, jumping 19.09% to $6.24 in the after-hours trading session on Tuesday, as investors got ready for the release of important clinical trial results.

Benzinga

A new strain of Covid is causing a spike in California as officials grapple with Trump’s vaccine policies

Health officials under Robert F. Kennedy Jr. have delayed and gummed up the approval of new Covid-19 jabs even as the new ‘Stratus’ subvariant surges in the Golden State

The Independent UK

Gyre Therapeutics Gains Attention As Under-The-Radar Liver Fibrosis Drug Maker

The global biopharmaceutical landscape is rapidly evolving, driven by innovations targeting complex diseases like organ fibrosis and liver conditions. As companies push the boundaries of medical science, new therapies are emerging that promise to transform patient care and redefine market leadership in these critical areas.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win

Argenx SE (NASDAQ:ARGX) stock is trading higher on continued upward momentum after the company released topline data on Monday from the pivotal Phase 3 ADAPT SERON study of Vyvgart (IV: efgartigimod alfa-fcab).

Grocery Coupon Guide

8 Fast-Food Ingredients That Have Quietly Been Pulled in Multiple States

The fast-food industry is under immense pressure from consumers to offer “cleaner” and healthier menu options. In response, many of the largest chains have been quietly reformulating their recipes to remove controversial and artificial ingredients. These changes often happen without a major national press announcement. The companies will simply pull…

Grocery Coupon Guide

Why Are Food Recalls Reported Late in Certain Southern States?

When a food product is recalled for a safety issue like Listeria or E. coli, a rapid and effective communication system is critical to protecting public health. Federal agencies like the FDA and the USDA will issue a national alert, but it is often up to state and local health…

The Independent UK

More than 20,000 cans of 7Up recalled over sugar label error

The sodas were distributed across several states and contain ‘full sugar’ says the FDA report

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

EXCLUSIVE: Virax Biolabs Inks Research Pact To Advance Long COVID Diagnostic Studies

Virax Biolabs Group Limited (NASDAQ:VRAX) announced on Tuesday that it had signed a Research Services Agreement (RSA) with Emory University's Center for the Advancement of Diagnostics for a Just Society (ADJUST Center) to conduct clinical studies of ViraxImmune.

GOBankingRates

7 Bills That Could Plummet by Next Year Under President Trump

Some financial experts remain optimistic that the administration's policies can help reduce other costs. So, will Trump lower bills?

Reason

Is This the Supreme Court's Next Big Abortion Case?

Plus: An impressive book by a Supreme Court justice.

Benzinga

Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

Shares of Serina Therapeutics Inc (NYSE:SER) rose sharply in pre-market trading after the company announced the FDA has provided written feedback supporting the advancement of SER-252.

MarketBeat

3 Biotech Catalysts Present Major Opportunity

Three promising biotech names stand out for potentially catalyzing drugs currently on the market or in development; here's why they may rally further.

Medical Daily

Friday Plans Reviews (2025): Should You Get Friday Plans? An Honest Look at Friday Plans Pills

To satisfy a growing number of reader questions about the service, this article delves into Friday Plans reviews, the ordering process, and the safety standards behind Friday Plans pills.

Benzinga

Tharimmune (THAR) Stock Is Surging Monday: What's Going On?

Shares of Tharimmune Inc (NASDAQ:THAR) are surging in Monday afternoon trading, continuing a rally that began last week. The stock’s rise comes in the absence of any company-specific news for the session, but follows last week’s announcement of promising simulation results for its lead clinical asset, TH104.

1 … 43 44 45 46

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

316 stories

the Centers for Disease Control and Prevention

227 stories

the Food and Drug Administration

the American Academy of Pediatrics

62 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.